Sulagna Bhattacharya

Nanoscope Therapeutics Appoints SVP of Regulatory and Quality

by | May 17, 2024
Khandan Baradaran, PhD, was most recently VP of regulatory CMC at Ultragenyx Pharmaceutical, a biopharmaceutical company involved in the research and development of novel products for the treatment of rare and ultra-rare genetic diseases.
MORE
Nanoscope Therapeutics Appoints New Chief Medical Officer
by | Apr 26, 2024
Dallas-based Nanoscope said Dr. Allen C. Ho will help define the strategy of developing its gene mutation-agnostic therapies. Ho is attending surgeon and director of retina research at Wills Eye Hospital and co-director of the Wills Eye Hospital Retina Service.
MORE
Nanoscope Therapeutics Names Finance and Biotech Leader as Board Chairman
by | Dec 8, 2023
Splendorio's more than 30 years of experience have been marked by extensive executive leadership in the ophthalmic industry, and he will support Nanoscope in reaching its strategic vision, the company said.
MORE
Nanoscope Therapeutics Names VP of Global Research and Development
by | Oct 27, 2023

Najam Sharif, Ph.D., DSc, has been appointed as vice president of global research and development by Dallas-based Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases.

Sharif is a veteran in drug/device discovery and development, the company said.

“We are delighted to welcome Naj to the Nanoscope team,” Sulagna Bhattacharya, co-founder and CEO of Nanoscope, said in a statement....

MORE

The Last Word: Health Wildcatters’ Dr. Hubert Zajicek on Dallas’ Biotech Boom

Dr. Zajicek and three other local biotech leaders—Sulagna Bhattacharya, CEO of Nanoscope Therapeutics; Gabby Everett, director of business operations and strategy at BioLabs Pegasus Park; and R.A. Session II, founder of Taysha Gene Therapies—discussed Dallas' biotech boom on a panel hosted by D CEO Healthcare.
MORE
Nanoscope Therapeutics Bolsters Board with Addition of Ophthalmic Veteran as Strategic Adviser
by | Mar 22, 2023
Nanoscope Therapeutics has enlisted the expertise of Vicente Anido Jr., Ph.D. to help the company advance its goal of developing sight-restoring gene therapies for retinal degenerative diseases. Anido's appointment as a strategic adviser is expected to support Nanoscope's clinical and corporate strategies, especially as the company progresses towards the potential commercialization of MCO-010.
MORE
The Future 50 in Dallas-Fort Worth 2023: Meet the Game-Changing Disruptors Driving Innovation and Impact
by | Mar 16, 2023
These standouts—startup founders, tech pioneers, educators, creators, social innovators, and business leaders—are transforming entire industries and making waves in their respective fields. 
MORE
Disruptors and Visionaries: The Startups of Dallas-Fort Worth’s Future 50 for 2023
by | Mar 16, 2023

Meet the startup innovators who are driving change in their industries and beyond. These startups are among the Future 50 in Dallas-Fort Worth, our editors’ picks of forward-thinking innovators who are shaping their industries and communities.

From the healthcare sector to the real estate industry, these trailblazers are disrupting the status quo with their groundbreaking technologies and solutions....

MORE

Nanoscope Therapeutics Names New Vice President of Quality

by | Jan 11, 2023

Nanoscope Therapeutics Inc., a Dallas-based clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has appointed Massoud Motamed, Ph.D., as vice president of quality.

Motamed brings nearly a decade of CGMP quality and compliance experience, including extensive experience in manufacturing and regulatory review of gene therapy products.

“Massoud’s experience leading quality and compliance in CGMP manufacturing for gene therapies will be valuable as we progress in our chemistry, manufacturing, and controls (CMC) capabilities....

MORE
Meet the 43 Finalists for the 2022 Tech Titans Awards
Every year, Tech Titans highlights the top movers and shakers in the North Texas technology ecosystem. Here are the finalists in 11 categories. Winners will be announced at the group's signature gala in October.
MORE
Meet the 11 Winners of the EY Entrepreneur Of The Year 2022 Central Plains Award
by | Jun 27, 2022
Ten of the 11 winners are from North Texas.
MORE
DI People: Addverb, Renibus Therapeutics, Denton EDP, Fort Worth Executive Roundtable, RumbleOn, and More Make Moves
In this week's roundup of hires, promotions, and accolades in North Texas, you'll also find news from VERTESS, Mr. Cooper, Active Cyber, EarthX, SWK Holdings, and more.

Plus, Fort Worth Mayor Mattie Parker makes an appointment to the city council's Entrepreneurship and Innovation Committee.
MORE